Executive Summary
The plaintiffs are seeking a permanent injunction against the defendants for infringing their patent related to the pharmaceutical product 'LORLATINIB'. The defendants are accused of manufacturing and selling an infringing product under the brand name 'LORBREXEN'.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Pfizer Inc vs Everest Pharmaceuticals Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Scipharm SarlvsAsstt. Controller Of Patents And Designs
Scipharm Sarl appealed a decision made by the Assistant Controller of Patents and Designs refusing the grant of a patent application titled 'Novel Composition for the Treatment of Cystic Fibrosis'. The case was transferred from the IPAB to the Delhi High Court. The court issued notice and directed both parties to file written submissions.
Fibrocell Technologies Inc.vsController Of Patents
Fibrocell Technologies Inc. appealed an impugned order dated February 19, 2019, passed by the Controller of Patents which denied its application (No. 10246/DELNP/2012). The appellant argued that the denial was based on new grounds (lack of enablement) and non-speaking reasons, violating natural justice.
Societe Des Produits Nestle S AvsThe Registrar Of Trade Marks
Nestle appealed a trademark refusal order from the Trademark Registry to the Delhi High Court. The original rejection was based on the mark being non-distinctive and similar to existing registered marks. Due to procedural issues following the dissolution of the IPAB, Nestle had to file a fresh appeal in the High Court. The court accepted notice and scheduled further proceedings.
M/S Shree Hari Industries (Hari Oil Mill)vsRegistrar of Copyrights and Anr
M/S Shree Hari Industries filed a suit against the Registrar of Copyrights alleging that respondents were selling mustard oil using an almost identical trade dress and packaging to the petitioner's product. The Delhi High Court addressed procedural matters, noting the emergence of evidence showing blatant copying by the respondents. While granting some time for the respondent to file necessary documentation, the court emphasized the seriousness of the infringement claim and fixed a firm date for the next hearing.
Franco Indian Pharmaceuticals Pvt. Ltd.vsCorona Remedies Pvt. Ltd.
The Bombay High Court addressed a trademark infringement suit filed by Franco Indian Pharmaceuticals against Corona Remedies concerning the marks STIMULIV and STIMULET. The core dispute involved the validity of the Defendant's trademark registration, which the Plaintiff challenged. Satisfied that the plea regarding invalidity was prima facie tenable, the court framed an issue on this matter and adjourned the suit for further proceedings.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.